metformin has been researched along with Peripheral Vascular Diseases in 4 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A low prevalence of AD in patients with T2D was associated with residency in urban areas, the comorbidity of hemiplegia or paraplegia, the usage of metformin and sulfonylureas, and rapid-acting insulin injection therapy." | 3.85 | Prevalence of anxiety disorder in patients with type 2 diabetes: a nationwide population-based study in Taiwan 2000-2010. ( Hsieh, HM; Huang, CJ; Jiang, HJ; Lin, CH; Tu, HP; Wang, PW, 2017) |
| "Treatment with metformin reduced mortality due to cardiovascular disease in obese patients." | 2.40 | [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications]. ( Heine, RJ; Wolffenbuttel, BH, 1999) |
| "63) and nine times less likely to adhere to their medications if they received more than once daily dosing of diabetic medication (OR = 0." | 1.40 | Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes. ( Almrayat, R; Alqudah, S; Jarab, AS; Khdour, M; Mukattash, TL; Pinto, S; Thehairat, E, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jarab, AS | 1 |
| Almrayat, R | 1 |
| Alqudah, S | 1 |
| Thehairat, E | 1 |
| Mukattash, TL | 1 |
| Khdour, M | 1 |
| Pinto, S | 1 |
| Tu, HP | 1 |
| Lin, CH | 1 |
| Hsieh, HM | 1 |
| Jiang, HJ | 1 |
| Wang, PW | 1 |
| Huang, CJ | 1 |
| Heikkinen, M | 1 |
| Salmenperä, M | 1 |
| Lepäntalo, A | 1 |
| Lepäntalo, M | 1 |
| Wolffenbuttel, BH | 1 |
| Heine, RJ | 1 |
2 reviews available for metformin and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Diabetes care for patients with peripheral arterial disease.
Topics: Anesthesia; Blood Pressure; Contrast Media; Diabetic Angiopathies; Diabetic Foot; Glycated Hemoglobi | 2007 |
[Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 1999 |
2 other studies available for metformin and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Drug Therapy, | 2014 |
Prevalence of anxiety disorder in patients with type 2 diabetes: a nationwide population-based study in Taiwan 2000-2010.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anxiety Disorders; Cerebrovascular Dis | 2017 |